Viridian Therapeutics, Inc.

VRDNNASDAQHealthcare● Active

$15.73

$-0.05(-0.32%)

Market Cap$1.4B

P/E Ratio—

52W High$34.29

52W Low$13.18

Avg Volume2.8M

Open$16.05

Beta0.90

Employees Ownership Insider Trades

Viridian Therapeutics, Inc. (VRDN) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · VRDN · as of Feb 26, 2026

Latest filing snapshot

252

+109+76.22%vs prior year

Viridian Therapeutics, Inc. (VRDN) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

252

Change (1Y)

+109

Growth % (1Y)

+76.22%

Revenue / Employee

$281.1K

Net Income / Employee

$-1.36M

Market Cap

$1.4B

VRDN Employee Count

2014 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-02-26	2025-12-31	252	+109	+76.22%
2025-03-03	2024-12-31	143	+49	+52.13%
2024-02-27	2023-12-31	94	+8	+9.30%
2023-03-09	2022-12-31	86	+36	+72.00%
2022-03-11	2021-12-31	50	+23	+85.19%
2021-03-26	2020-12-31	27	-19	-41.30%
2020-03-13	2019-12-31	46	-34	-42.50%
2019-03-14	2018-12-31	80	+15	+23.08%
2018-03-15	2017-12-31	65	+20	+44.44%
2017-03-24	2016-12-31	45	+13	+40.63%

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

Viridian Therapeutics, Inc.YOU

252$1.4B #4

COGT

Cogent Biosciences, Inc.

205$5.3B #5

CLDX

Celldex Therapeutics, Inc.

186$1.9B #6

GPCR

Structure Therapeutics Inc.

163$2.2B #7

EWTX

Edgewise Therapeutics, Inc.

117$3.7B

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · VRDN peer comparison

About VRDN employees

VRDN Employees · Headcount

Viridian Therapeutics, Inc. (VRDN) employee data is sourced from the annual SEC 10-K filing. As of 2025, Viridian Therapeutics, Inc. had 252 full-time employees globally. Full-time employees only. Global consolidated headcount.

Viridian Therapeutics, Inc. employs 252 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $281,147, reflecting the company's operational efficiency.

Viridian Therapeutics, Inc.'s workforce increased by 109 (76.22%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Viridian Therapeutics, Inc.'s revenue per employee of $281,147 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

VRDN Employees · 5 questions

As of the latest SEC 10-K filing (2025), Viridian Therapeutics, Inc. had 252 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Viridian Therapeutics, Inc. employee counthow many employees does Viridian Therapeutics, Inc. haveVRDN total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-02-26